No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 2.4x · 10Y median 2.5x · 42nd percentile · as of Sep 11, 2026
Annual revenue · last 4 fiscal years + TTM
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-09-24T00:16:27.587Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-09-24T00:16:27.587Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-09-24T00:16:27.587Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-09-24T00:16:27.587Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-09-24T00:16:27.587Z. Latest historical point 2026-09-11.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-09-24T00:16:27.587Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-09-24T00:16:27.587Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-09-24T00:16:27.587Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Solstice Advanced Materials Inc. (SOLS) stock was $57.98 as of Sep 23, 2026, 4:00 PM EDT, down 1.55% from the previous close.
Solstice Advanced Materials, Inc. functions as a dedicated provider of specialized materials.
Chemicals - Specialty · Morris Plains, NJ
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Next Earnings Date
Oct 29, 2026
35 days away
EPS Estimate
0.72
Revenue Est.
$1.02B
Last Quarter Results
EPS
$0.88
vs Estimate
$0.77
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1SOLS | $9.21B | $57.98 | -1.55% | N/A | N/A | N/A | N/A |
| 2AG | $9.39B | $19.05 | -6.25% | +88.78% | +10.19% | +4.90% | vs SOLS |
| 3MP | $8.70B | $48.89 | -4.21% | -19.88% | +8.16% | N/A | vs SOLS |
| 4MOS | $7.75B | $24.37 | -1.46% | -22.49% | -2.10% | +1.20% | vs SOLS |
| 5ACA | $7.19B | $146.50 | -0.07% | +48.00% | +24.48% | N/A | vs SOLS |
| 6AA | $11.63B | $44.06 | -1.45% | +50.68% | +0.50% | +8.96% | vs SOLS |
TTM
2.25
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
$1.15B
vs Estimate
$1.08B
Consensus Rating
Based on 8 analysts
Average Price Target
$80.25
+38.4% upside
Low
$70.00
Current
$57.98
High
$86.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $0.69 | $0.70 | $0.70 | 4 |
| Quarter ending Dec 2026 | $0.70 | $0.71 | $0.71 | 4 |
| Quarter ending Mar 2027 | $0.69 | $0.70 | $0.71 | 1 |
| Quarter ending Jun 2027 | $1.03 | $1.03 | $1.04 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $2.86 | $2.89 | $2.92 | 5 |
| FY 2027 | $3.17 | $3.36 | $3.45 | 5 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $1.01B | $1.02B | $1.03B | 3 |
| Quarter ending Dec 2026 | $1.01B | $1.02B | $1.02B | 3 |
| Quarter ending Mar 2027 | $1.04B | $1.04B | $1.05B | 1 |
| Quarter ending Jun 2027 | $1.20B | $1.21B | $1.22B | 1 |
Annual
| Period | Low |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Dec 31, 2026, matching Key Metrics.
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $4.12B | $4.17B | $4.18B | 6 |
| FY 2027 | $4.37B | $4.41B | $4.45B | 6 |
